McPartland R P, Rapp J P, Sustarsic D L
Endocr Res Commun. 1981;8(3):145-53. doi: 10.3109/07435808109045735.
The effect of glucocorticoid treatment on urinary kallikrein excretion was assessed in Dahl salt-hypertension susceptible (S) and salt-hypertension resistant (R) rats. A single dose of dexamethasone (100 micrograms) caused a marked water diuresis and a slight decrease in urinary kallikrein excretion in both S and R rats. A single dose of dexamethasone also caused the S rat to excrete massive amounts of protein into the urine, almost 3-fold higher than S rats treated with oil; the effect on R rat urinary protein was similar, but less severe. Daily administration of dexamethasone (100 micrograms/day) for 7 days caused marked suppression of urinary kallikrein excretion in both S and R rats. Increased urinary protein following chronic treatment was still evident in the dexamethasone-treated S rats but not in the dexamethasone-treated R rats. Chronic glucocorticoid treatment probably inhibits urinary kallikrein activity by suppressing pituitary and adrenal function which would remove the stimulatory effect of aldosterone on urinary kallikrein excretion. There was no evidence for a stimulatory role of glucocorticoids on urinary kallikrein.
在Dahl盐敏感性高血压(S)大鼠和盐抵抗性高血压(R)大鼠中评估了糖皮质激素治疗对尿激肽释放酶排泄的影响。单次给予地塞米松(100微克)可引起明显的水利尿,且S和R大鼠的尿激肽释放酶排泄均略有下降。单次给予地塞米松还使S大鼠尿中排泄大量蛋白质,几乎比用油处理的S大鼠高3倍;对R大鼠尿蛋白的影响相似,但程度较轻。连续7天每日给予地塞米松(100微克/天)可导致S和R大鼠的尿激肽释放酶排泄明显受抑制。地塞米松治疗的S大鼠经慢性治疗后尿蛋白增加仍很明显,但地塞米松治疗的R大鼠则不明显。慢性糖皮质激素治疗可能通过抑制垂体和肾上腺功能来抑制尿激肽释放酶活性,而垂体和肾上腺功能的抑制会消除醛固酮对尿激肽释放酶排泄的刺激作用。没有证据表明糖皮质激素对尿激肽释放酶有刺激作用。